Bristol-Myers Squibb: This High FCF Yield Is The Best Value In Healthcare

Group 1 - Bristol-Myers Squibb is identified as a potential value investment in the healthcare sector, with strong fundamentals and good cash flows [1] - The focus is on undervalued companies or industries that have been overlooked, such as Energy Transfer, which has shown resilience despite market disinterest [1] - The investment strategy emphasizes long-term value investing while also exploring deal arbitrage opportunities in various sectors [1] Group 2 - The analyst expresses a preference for sectors like Oil & Gas and consumer goods, while avoiding high-tech and certain consumer goods that are difficult to understand [1] - There is skepticism towards cryptocurrencies as an investment option, indicating a preference for more traditional assets [1] - The goal is to connect with like-minded investors through platforms like Seeking Alpha to share insights and foster a collaborative investment community [1]